Both medications embody a innovative class of protein therapies designed to inhibit the coronavirus virus . Initially , sotrovimab, created by the companies, demonstrated substantial benefit against https://finniansluw257825.aboutyoublog.com/53811849/sotrovimab-vir-7831-a-deep-exploration-into-the-protein-therapy